Scarica l'app Stockscreener
241.50
0.47%
2.0025
Precedente Chiudi:
$239.50
Aprire:
$240.16
Volume 24 ore:
10,842
Relative Volume:
0.02
Capitalizzazione di mercato:
$9.37B
Reddito:
$1.24B
Utile/perdita netta:
$42.23M
Rapporto P/E:
227.83
EPS:
1.06
Flusso di cassa netto:
$150.33M
1 W Prestazione:
+0.22%
1M Prestazione:
+1.13%
6M Prestazione:
-9.90%
1 anno Prestazione:
+42.56%
Intervallo 1D:
$239.14
$240.16
Intervallo di 1 settimana:
$234.34
$243.27
Portata 52W:
$174.23
$310.00
Penumbra Inc Stock (PEN) Company Profile
Nome
Penumbra Inc
Settore
Industria
Telefono
(510) 995-2486
Indirizzo
ONE PENUMBRA PLACE, ALAMEDA, CA
Confronta PEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
240.15 | 9.38B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
130.44 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.69 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
379.03 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.46 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.78 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-14 | Iniziato | BofA Securities | Buy |
| 2025-01-21 | Iniziato | UBS | Buy |
| 2024-12-17 | Iniziato | Oppenheimer | Outperform |
| 2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | Iniziato | Stifel | Buy |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-31 | Downgrade | Citigroup | Buy → Neutral |
| 2024-07-31 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-29 | Downgrade | Needham | Buy → Hold |
| 2023-01-30 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-10-05 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-09 | Aggiornamento | Needham | Hold → Buy |
| 2022-07-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-04-19 | Iniziato | Deutsche Bank | Buy |
| 2022-03-08 | Iniziato | Needham | Hold |
| 2021-09-16 | Iniziato | Truist | Buy |
| 2021-06-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-07 | Ripresa | Canaccord Genuity | Buy |
| 2020-09-29 | Iniziato | BTIG Research | Buy |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-05-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Iniziato | William Blair | Outperform |
| 2018-10-29 | Ripresa | BofA/Merrill | Buy |
| 2018-10-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-02-21 | Iniziato | William Blair | Outperform |
| 2018-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-13 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Penumbra Inc Borsa (PEN) Ultime notizie
PEN Q2 Deep Dive: Sales Force Expansion and Clinical Milestones Drive Outperformance - ca.finance.yahoo.com
5 Insightful Analyst Questions From Penumbra’s Q2 Earnings Call - ca.finance.yahoo.com
Penumbra Inc. Breaks Losing Streak — Is the Trend ReversingWeekly Chart Analysis With Entry Advice Provided - metal.it
Aspiration Thrombectomy Device Market Set to Witness - openPR.com
What makes Penumbra Inc. stock price move sharplyEarly Entry Picks Before News Breakout Reviewed - metal.it
Penumbra Inc.: Thrombectomy Business Expansion As a Significant Driver For Overall Market Share Growth! - Smartkarma
MACD Signals Flash Warning for Penumbra Inc. StockOptimized Watchlist With Daily Adjustments Launched - metal.it
How volatile is Penumbra Inc. stock compared to the marketAchieve breakthrough growth with proven strategies - Jammu Links News
Is it the right time to buy Penumbra Inc. stockBreakthrough profits - Jammu Links News
What are analysts’ price targets for Penumbra Inc. in the next 12 monthsRapid return acceleration - Jammu Links News
How strong is Penumbra Inc. company’s balance sheetFree Bull & Bear Market Updates - Jammu Links News
Is Penumbra Inc. a growth stock or a value stockAccelerated capital growth - Jammu Links News
Penumbra Inc. Stock Analysis and ForecastInvest smarter with real-time trading alerts - Jammu Links News
What are the latest earnings results for Penumbra Inc.Spectacular growth rates - Jammu Links News
What is the risk reward ratio of investing in Penumbra Inc. stockDiscover investment plans that deliver results - Jammu Links News
What are Penumbra Inc. company’s key revenue driversRapid portfolio appreciation - Jammu Links News
What institutional investors are buying Penumbra Inc. stockFree Risk Assessment Services - Jammu Links News
Results: Penumbra, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Penumbra, Inc. Reports Second Quarter 2025 Financial Results - ADVFN Brasil
Penumbra price target raised to $325 from $316 at Baird - TipRanks
Penumbra's Strong Growth Potential and Strategic Developments Support Buy Rating with $327 Price Target - AInvest
UBS Analyst Increases Penumbra's Price Target to $335 - AInvest
Penumbra to Present at Canaccord Genuity 45th Annual Growth Conference - AInvest
Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference - Eastern Progress
Morgan Stanley Raises Price Target for Penumbra (PEN) to $266 | - GuruFocus
Should You Invest in Penumbra (PEN)? - Insider Monkey
Penumbra, Inc. (NYSE:PEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Penumbra Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Penumbra outlines 13% to 15% revenue growth target for 2025 as thrombectomy adoption accelerates - MSN
Penumbra Inc. Reports Strong Q2 Earnings with Growth in U.S. Thrombectomy - TipRanks
Penumbra Surges 11.9% on Q2 Earnings Beat and Margin Expansion as $300M Volume Pushes It to 407th Trading Rank - AInvest
Penumbra (PEN) Q2 Revenue Jumps 13% - AOL.com
Penumbra (PEN) Shares Skyrocket, What You Need To Know - Yahoo Finance
Penumbra stock price target lowered to $325 at RBC Capital on margin outlook - Investing.com India
Penumbra: Truist Securities maintains a 'Buy' Rating, The Target Price is $310 - AInvest
Penumbra (PEN) Analyst Rating Update: Baird Raises Price Target - GuruFocus
Penumbra (PEN) Price Target Revised by RBC Capital | PEN Stock N - GuruFocus
Penumbra (PEN) Price Target Raised by Truist Following Earnings Beat - GuruFocus
Penumbra stock price target raised to $335 from $330 at UBS on solid growth - Investing.com
Penumbra (PEN) Price Target Raised by Baird to $285 - GuruFocus
Penumbra (PEN) Target Price Raised by Canaccord Genuity | PEN St - GuruFocus
Penumbra price target raised to $335 from $330 at UBS - TipRanks
Why Did Penumbra Stock Soar 14.46%? - AInvest
S&P 500 Futures Climb in Premarket Trading; Penumbra, Marvell Technology Lead - Barron's
Why Penumbra Inc. stock attracts strong analyst attentionScalable Portfolio Growth Suggestions Released - metal.it
Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Penumbra Inc earnings beat by $0.03, revenue topped estimates - Investing.com Australia
Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Penumbra, Inc. Reports Strong Q2 2025 Results - TipRanks
Penumbra 2025 Q2 Earnings Strong Performance as Net Income Swings to Profit - AInvest
Penumbra Inc Azioni (PEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):